News from cepheid A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 04, 2016, 16:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Jul 28, 2016, 16:05 ET Cepheid Reports Second Quarter 2016 Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the second quarter of 2016 of $146.0 million, representing growth of 10%, or 12% on a...


Jul 12, 2016, 08:00 ET Cepheid Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening

Cepheid (Nasdaq: CPHD) today announced the publication of a validation study assessing the use of Xpert HPV (Human Papillomavirus) as a front-line...


Jul 07, 2016, 16:05 ET Cepheid Schedules 2016 Second Quarter Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2016 second quarter on Thursday, July 28, 2016, after the...


Jul 05, 2016, 09:00 ET Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services

 Cepheid (Nasdaq: CPHD) today applauded the opening of the 10 Hammersmith Broadway Sexual Health clinic in London, England. The Hammersmith...


Jun 30, 2016, 08:00 ET FDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"

SUNNYVALE, Calif., June 30, 2016 /PRNewswire/-- Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug...


Jun 15, 2016, 08:30 ET Cepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test

 Cepheid (Nasdaq: CPHD) today announced that its Xpert® HIV-1 Qual (Qualitative) test has been awarded World Health Organization (WHO)...


May 05, 2016, 08:00 ET US National TB Controllers Association And Association Of Public Health Laboratories Issue Guidance For Use Of Xpert MTB/RIF To Support Respiratory Isolation Decisions

Cepheid (Nasdaq: CPHD) today welcomed publication of new guidance from the US National Tuberculosis Controllers Association (NTCA) and the...


May 03, 2016, 08:00 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Apr 28, 2016, 16:05 ET Cepheid Reports First Quarter 2016 Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the first quarter of 2016 of $144.8 million, representing growth of 9%, or 13% on a constant...


Apr 21, 2016, 16:05 ET Cepheid Announces Partner Distribution Agreement With Medline

Cepheid (Nasdaq: CPHD) today announced an agreement with Medline, the largest privately held distributor of healthcare products in the United...


Apr 11, 2016, 03:05 ET Using 'Diagnostics First' Could Help Preserve Effectiveness Of Life-Saving Antibiotics

 Cepheid (Nasdaq: CPHD) today announced the launch of its 'Diagnostics First' campaign to raise awareness for the use of accurate and fast...


Apr 07, 2016, 16:05 ET Cepheid Schedules 2016 First Quarter Results Announcement And Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2016 first quarter on Thursday, April 28, 2016, after the...


Mar 29, 2016, 08:00 ET Cepheid Announces European Approval Of Xpert MRSA Next Generation (NxG) Screening Test

Cepheid (Nasdaq: CPHD) today announced commercial availability, outside the United States, of Xpert® MRSA NxG, a next generation version of...


Mar 24, 2016, 08:00 ET Cepheid Recognizes World TB Day 2016 With Delivery Of 5,000th GeneXpert System To Support Global Fight Against Tuberculosis And Multi-Drug Resistant Tuberculosis

 Cepheid (Nasdaq: CPHD) today recognized World TB Day 2016 with the delivery of the 5,000th GeneXpert® System to be deployed as part of...


Mar 09, 2016, 08:00 ET Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs'

 Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert®...


Mar 07, 2016, 08:00 ET Cepheid Delivers Milestone 10,000th GeneXpert System

Cepheid (Nasdaq: CPHD) today announced the delivery of the 10,000th GeneXpert® System to the 10 Hammersmith Broadway Clinic in London,...


Feb 10, 2016, 16:05 ET Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations

 Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted...


Feb 03, 2016, 16:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Feb 02, 2016, 16:02 ET Cepheid Reports Fourth Quarter And Full Year 2015 Results

Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2015 of $147.0 million, representing growth of 12% from $131.5 million for...


Jan 13, 2016, 16:05 ET Cepheid Announces Diagnostic Collaboration With MedImmune And COMBACTE To Facilitate Clinical Trials Of New Monoclonal Antibodies To Prevent Serious Infectious Diseases

 Cepheid (Nasdaq: CPHD) today announced a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, and...


Jan 11, 2016, 08:00 ET Cepheid Schedules 2015 Fourth Quarter And Full Year Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2015 fourth quarter and full year ended December 31, 2015...


Jan 07, 2016, 08:00 ET USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis

 Cepheid (NASDAQ: CPHD) today announced that it has signed a Memorandum of Understanding (MOU) representing the intention of the company,...


Jan 05, 2016, 08:00 ET Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...


Jan 04, 2016, 08:00 ET Cepheid Announces Distribution Agreement with Henry Schein

 Cepheid (NASDAQ: CPHD) today announced an agreement with Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., for the...